March 27, 2015
On April 23, 2015 at 6:00 pm, David P. Hesson, PhD, CEO, LytPhage, Inc will present "LytPhage - Story of local resources leading to identification of the commercial path and company formation" for the LES Philadelphia Chapter at Quorum University City, Science Center, 3711 Market Street, Suite 800, Philadelphia, PA.
Panelists will cover how these programs helped to uncover the critical path for commercial development leading to new company formation (start up), large corporate collaboration, and (hopefully) to early financing.
David Hesson, PhD, CEO, LytPhage, Inc.
Ken Kilgore, MS, PhD, Director, Parnered Pharmacology, Immunology Therapeutic Area
Christopher Laing, MRCVS, PhD, Vice President Science and Technology, University City
Todd Abrams, PhD, Senior Director, New Ventures and Business Developments, Temple University
LytPhage, a local start up company, out of Temple University, is developing a novel antibiotic product that harnesses genetically-modified bacterial viruses (phage).